MDT Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
9.8B
+8.8%
9.0B
+0.6%
9.0B
+4.5%
8.6B
-3.9%
8.9B
Cost of Revenue
3.4B
+4.2%
3.3B
+6.5%
3.1B
+2.0%
3.0B
-4.6%
3.1B
Gross Profit
6.4B
+11.3%
5.8B
-2.4%
5.9B
+5.8%
5.6B
-3.5%
5.8B
Operating Expenses
4.7B
+9.5%
4.3B
+1.6%
4.2B
+3.2%
4.1B
-5.6%
4.3B
R&D
671.0M
-7.1%
722.0M
-4.2%
754.0M
+3.9%
726.0M
+6.1%
684.0M
SG&A
3.1B
+3.4%
3.0B
-0.3%
3.0B
+5.7%
2.8B
+3.2%
2.7B
Operating Income
1.7B
+16.6%
1.5B
-12.3%
1.7B
+12.8%
1.5B
+2.7%
1.5B
EBITDA
2.7B
+15.9%
2.3B
-5.6%
2.5B
+5.5%
2.3B
-16.0%
2.8B
Net Income
1.3B
+9.5%
1.1B
-16.9%
1.4B
+32.0%
1.0B
-1.4%
1.1B
EPS (Basic)
$0.97
+9.0%
$0.89
-16.8%
$1.07
+32.1%
$0.81
-1.2%
$0.82
EPS (Diluted)
$0.97
+9.0%
$0.89
-16.8%
$1.07
+32.1%
$0.81
-1.2%
$0.82
Shares (Diluted)
1.3B
-0.1%
1.3B
+0.1%
1.3B
+0.1%
1.3B
-0.2%
1.3B
Medtronic (MDT) โ€” Financials